QuikClot
Commercial- Indications
- Hemorrhage control
Company intelligence / Profile preview
Z-Medica
Wallingford, Connecticut, United Statesz-medica.com ↗
- Ownership
- Private
- Employees
- ~434
- Development stage
- Commercial
01
Overview
QuikClot products are FDA-cleared and CE-marked commercial devices for rapid hemorrhage control. They are widely adopted by the US military as first-line treatment for traumatic bleeding and used globally in hospitals, emergency response, law enforcement, and military settings. Clinical studies have demonstrated their effectiveness in accelerating clot formation and improving patient outcomes.
- Therapeutic areas
- CardiovascularHematology
- Modalities
- Device (Hemostatic device)Biologic (kaolin-based hemostatic agent)
- Industry
- Consumable Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Stöpler Instrumenten & Apparaten B.V. (Netherlands distribution)
Beyond the preview
Go deeper on Z-Medica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Z-Medica.